A survey of The Cancer Genome Atlas (TCGA) suggests that CDH11 expression is also elevated in many other cancers including breast cancer (BRCA), cholangiocarcinoma (CHOL), colon adenocarcinoma (COAD), esophageal carcinoma (ESCA), head and neck cancer (HNSC), stomach adenocarcinoma (STAD) and glioblastoma (GBM) (Figure S9). Here, CDH11 is linked to colon adenocarcinoma.